Yaccoby S - Search Results

1

Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.

Chen L, Wang S, Zhou Y, Wu X, Entin I, Epstein J, Yaccoby S, Xiong W, Barlogie B, Shaughnessy JD Jr, Zhan F. Chen L, et al. Among authors: yaccoby s. Blood. 2010 Jan 7;115(1):61-70. doi: 10.1182/blood-2009-03-210526. Epub 2009 Oct 16. Blood. 2010. PMID: 19837979 Free PMC article.

2

Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations.

Yaccoby S, Barlogie B, Epstein J. Yaccoby S, et al. Blood. 1998 Oct 15;92(8):2908-13. Blood. 1998. PMID: 9763577 Free article.

3

The proliferative potential of myeloma plasma cells manifest in the SCID-hu host.

Yaccoby S, Epstein J. Yaccoby S, et al. Blood. 1999 Nov 15;94(10):3576-82. Blood. 1999. PMID: 10552969 Free article.

4

Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins.

Børset M, Hjertner O, Yaccoby S, Epstein J, Sanderson RD. Børset M, et al. Among authors: yaccoby s. Blood. 2000 Oct 1;96(7):2528-36. Blood. 2000. PMID: 11001907 Free article.

5

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

Pearse RN, Sordillo EM, Yaccoby S, Wong BR, Liau DF, Colman N, Michaeli J, Epstein J, Choi Y. Pearse RN, et al. Among authors: yaccoby s. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11581-6. doi: 10.1073/pnas.201394498. Epub 2001 Sep 18. Proc Natl Acad Sci U S A. 2001. PMID: 11562486 Free PMC article.

6

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.

Yaccoby S, Pearse RN, Johnson CL, Barlogie B, Choi Y, Epstein J. Yaccoby S, et al. Br J Haematol. 2002 Feb;116(2):278-90. doi: 10.1046/j.1365-2141.2002.03257.x. Br J Haematol. 2002. PMID: 11841428 Free article.

7

Soluble syndecan-1 promotes growth of myeloma tumors in vivo.

Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, Epstein J, Sanderson RD. Yang Y, et al. Among authors: yaccoby s. Blood. 2002 Jul 15;100(2):610-7. doi: 10.1182/blood.v100.2.610. Blood. 2002. PMID: 12091355 Free article.

8

Antimyeloma efficacy of thalidomide in the SCID-hu model.

Yaccoby S, Johnson CL, Mahaffey SC, Wezeman MJ, Barlogie B, Epstein J. Yaccoby S, et al. Blood. 2002 Dec 1;100(12):4162-8. doi: 10.1182/blood-2002-03-0939. Epub 2002 Aug 8. Blood. 2002. PMID: 12393672 Free article.

9

Consequences of interactions between the bone marrow stroma and myeloma.

Epstein J, Yaccoby S. Epstein J, et al. Among authors: yaccoby s. Hematol J. 2003;4(5):310-4. doi: 10.1038/sj.thj.6200313. Hematol J. 2003. PMID: 14502254 Review.

10

Cancer and the microenvironment: myeloma-osteoclast interactions as a model.

Yaccoby S, Wezeman MJ, Henderson A, Cottler-Fox M, Yi Q, Barlogie B, Epstein J. Yaccoby S, et al. Cancer Res. 2004 Mar 15;64(6):2016-23. doi: 10.1158/0008-5472.can-03-1131. Cancer Res. 2004. PMID: 15026338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters